Affymetrix tech to save pharma 'billions'
Researchers from Germany's Fraunhofer Institute are using Affymetrix' assay technology to develop tests that detect drug induced liver injury (DILI).
Researchers from Germany's Fraunhofer Institute are using Affymetrix' assay technology to develop tests that detect drug induced liver injury (DILI).
Agilent has continued its summer spending spree with the acquisition of US-based Particle Sizing Systems that will further bolster the firm's Materials Science Services Unit (MSSU).
PerkinElmer has created the ViaCord Research Institute (VRI) to investigate new uses of stem cells derived from umbilical cord blood.
Avir Green Hills Biotechnology's intranasal vaccine deltaFLU for the treatment of pandemic influenza is commencing Phase I clinical trials.
Sangamo Biosciences and Sigma-Aldrich have licensed their zinc finger nuclease (ZFN) technology to Roche to enable the pharma giant to develop cell lines and transgenic animals.
The splurge of acquisitions by Worldwide Clinical Trials (WCT) is continuing unabated with the company wrapping up the take over of MediQuest.
Electron microscopy expert FEI has launched a new range of scanning electron microscopes (SEM) that enables sub-nanometre 3D surface imaging.